NASDAQ:PCSA | Cash Flow Statement | Processa Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2012-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.27M
2026-03-31-$3.38M-$3.59M-$500,000.00$244,783.00
2025-12-31-$3.36M-$2.9M$2.98M
2025-09-30-$3.44M
2025-06-30-$3.93M
2025-03-31-$2.83M-$2.73M$4.44M
2024-12-31-$2.73M-$2.25M$0.00$0.00$547,582.00
2024-09-30-$3.38M
2024-06-30-$3.01M
2024-03-31-$2.73M-$2.05M$6.26M
2023-12-31-$2.4M-$2.12M$0.00$0.00-$30,607.00
2023-09-30-$2.08M
2023-06-30-$2.61M
2023-03-31-$4.02M-$2.11M$6.35M
2022-12-31-$13.01M-$2.5M-$53,596.00
2022-09-30-$6.02M
2022-06-30-$5.16M
2022-03-31-$3.23M-$1.8M-$300,000.00
2021-12-31-$3.18M-$2.73M$131,363.00
2021-09-30-$2.99M
2021-06-30-$3.16M
2021-03-31-$2.1M-$2.24M$9.88M
2020-12-31-$9.73M-$2.28M$17.37M
2020-09-30-$3.07M
2020-06-30-$733,414.00
2020-03-31-$874,336.00-$546,453.00-$2,806.00
2019-12-31-$774,443.00-$613,486.00$800,720.00
2019-09-30-$863,524.00
2019-06-30-$969,077.00
2019-03-31-$750,832.00-$607,429.00$115,000.00
2018-12-31-$609,173.00-$463,976.00$0.00-$219,286.00
2018-09-30-$852,822.00
2018-06-30-$1.21M
2018-03-31-$1.1M-$1.07M-$1,782.00
2017-12-31-$633,862.00-$675,794.00-$14,342.00$2.5M
2017-09-30-$711,567.00
2017-06-30-$278,445.00
2017-03-31-$232,442.00-$58,698.00$882.00-$882.00
2016-12-31-$1.67M-$2.12M-$1.06M$4.26M
2016-09-30-$68,333.00
2016-06-30-$43,200.00
2016-03-31-$133,625.00-$50,369.00$27,000.00$15,000.00
2015-12-31-$362,766.00-$46,070.00$0.00$41,603.00$0.00
2015-09-30-$295,743.00
2015-06-30-$2.05M
2015-03-31-$644,606.00-$502,088.00$1,399.00$1,399.00$524,036.00
2014-12-31-$1.54M-$455,573.00-$14,712.00-$22,580.00$447,463.00
2014-09-30-$791,954.00
2014-06-30-$851,216.00
2014-03-31-$1.34M-$987,738.00$13,772.00-$10,417.00$893,539.00
2013-12-31-$806,925.00-$462,538.00$1.00-$1.00-$346,534.00
2013-09-30-$718,840.00
2013-06-30-$726,571.00
2013-03-31-$816,365.00-$592,973.00$6,276.00-$6,276.00-$6,737.00
2012-12-31-$782,940.00-$647,828.00$14,376.00-$14,376.00$291,366.00
2012-09-30-$601,882.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$13.56M-$11.39M-$850,000.00$16.58M
2024-12-31-$11.85M-$11.25M$3,244.00-$3,244.00$7.73M
2023-12-31-$11.12M-$8.06M$2,776.00-$2,776.00$6.27M
2022-12-31-$27.42M-$9.61M-$388,843.00
2021-12-31-$11.43M-$8.72M$9.8M
2020-12-31-$14.41M-$3.14M$17.87M
2019-12-31-$3.36M-$2.75M$1.7M
2018-12-31-$3.77M-$3.71M-$22,282.00$2.62M
2017-12-31-$1.86M-$1.65M$20,622.00$1M$2.43M
2016-12-31-$1.92M-$2.16M$23,775.00-$1.04M$4.27M
2015-12-31-$3.35M-$871,906.00$1,399.00$40,204.00$42,942.00$821,098.00
2014-12-31-$4.53M-$2.69M$11,007.00-$44,944.00$45,590.00$2.57M
2013-12-31-$3.07M-$2.54M$27,674.00-$27,674.00$1.73M
2012-12-31-$2.44M-$1.89M$334,338.00-$334,338.00$453,376.00